| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Legend Biotech (NASDAQ:LEGN) will release its quarterly earnings report on Wednesday, 2025-11-12. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Legend Biotech to report an earnings per share (EPS) of $-0.12.
Investors in Legend Biotech are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
During the last quarter, the company reported an EPS missed by $0.13, leading to a 2.07% increase in the share price on the subsequent day.
Here's a look at Legend Biotech's past performance and the resulting price change:
| Quarter | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.21 | -0.25 | -0.33 | -0.42 |
| EPS Actual | -0.34 | -0.07 | -0.15 | -0.34 |
| Price Change % | 2.00 | -11.00 | 3.00 | -2.00 |
Shares of Legend Biotech were trading at $31.59 as of November 10. Over the last 52-week period, shares are down 19.72%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
To track all earnings releases for Legend Biotech visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: LEGN
